Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

MLA

Guillaume, Voiriot, et al. Combined Use of a Broad-Panel Respiratory Multiplex PCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients with Severe Community-Acquired Pneumonia (MULTI-CAP): A Multicentre, Parallel-Group, Open-Label, Individual Randomised Trial Conducted in French Intensive Care Units. Jan. 2021. EBSCOhost, https://doi.org/10.1136/bmjopen-2020-048187⟩.

APA

Guillaume, V., Muriel, F., Isabelle, D.-Z., Laurence, B., Alexandra, R., Laurence, A.-L., Charlotte, V., Laurent, A., Kada, K., Bruno, M., Juliette, P., Jean-Christophe, R., Jean, R., Carole, S., Bertrand, S., Yacine, T.-L., Tabassome, S., Jean-François, T., & Saad, N. (2021). Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units. https://doi.org/10.1136/bmjopen-2020-048187⟩

Chicago

Guillaume, Voiriot, Fartoukh Muriel, Durand-Zaleski Isabelle, Berard Laurence, Rousseau Alexandra, Armand-Lefevre Laurence, Verdet Charlotte, et al. 2021. “Combined Use of a Broad-Panel Respiratory Multiplex PCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients with Severe Community-Acquired Pneumonia (MULTI-CAP): A Multicentre, Parallel-Group, Open-Label, Individual Randomised Trial Conducted in French Intensive Care Units,” January. doi:10.1136/bmjopen-2020-048187⟩.